Class I medical device registration with Brazil’s National Health Surveillance Agency (ANVISA) is a regulatory process designed for low-risk medical devices. These devices require a simpler registration pathway due to their low-risk nature, and this is often referred to as "Cadastro" (registration) rather than "Registro" (higher scrutiny, applicable for higher-risk devices). Here’s a breakdown of Class I device registration and how to apply:
What is Class I Medical Device Registration with ANVISA?
Class I devices are categorized as low-risk products under ANVISA’s classification system. These are typically items that have minimal impact on patient health if they fail, and they don't require extensive testing or documentation like higher-risk (Class II, III, or IV) devices. Typical Class I devices may include simple surgical instruments, certain patient aids, or low-complexity equipment.
Steps to Apply for Class I Medical Device Registration with ANVISA
Identify Device Classification:
- Confirm that the product qualifies as a Class I device under ANVISA’s risk classification. Brazil follows a classification system similar to the EU (Class I, II, III, and IV).
Obtain a Brazilian Registration Holder (BRH):
- Foreign manufacturers must appoint a Brazilian Registration Holder (BRH) to represent them with ANVISA. This local representative acts as the official liaison with ANVISA.
Prepare Required Documentation:
- For Class I devices, ANVISA requires a dossier with basic information and technical documentation. Key documents include:
- Device Description: Information on device design, components, materials, and purpose.
- Instructions for Use and Labeling: A comprehensive guide on how the device should be used safely.
- Quality Management System (QMS): Proof of QMS compliance, often with ISO 13485 certification, though Brazil-specific documentation may also be required.
Complete the Dossier:
- ANVISA requires a device dossier tailored to the product’s risk class. For Class I, the documentation is lighter and focuses on demonstrating safety and effectiveness.
Submit the Registration Application via the ANVISA System:
- Submissions are made electronically through ANVISA’s platform. The BRH will submit the required dossier along with the application form.
Pay the Applicable Fees:
- Fees vary based on device class and company size. Fees for Class I are generally lower than those for higher-risk devices.
ANVISA Review and Approval:
- ANVISA will review the dossier, ensuring the device meets all safety and labeling standards. For Class I devices, this is a streamlined process that typically takes less time than higher-risk classes, though timelines may vary.
Obtain Approval and Register the Device:
- Once approved, the device is listed with ANVISA and can be marketed in Brazil. Registration must be renewed every five years.
Post-Market Obligations:
- Maintain compliance with ANVISA's post-market surveillance requirements, which include reporting adverse events and device performance monitoring.
Tips for a Smooth Registration Process
- Collaborate with a Local Partner: Working with a reliable Brazilian Registration Holder simplifies communication with ANVISA.
- Ensure Document Accuracy: Verify that all documentation is complete and accurate to avoid delays during ANVISA's review.
- Stay Informed on ANVISA’s Regulations: Brazil's regulatory requirements can change, so staying up-to-date with ANVISA's guidelines is crucial.
For further guidance, ANVISA offers resources on its website, or a local regulatory expert can provide personalized assistance through the registration process.
Contact Us:
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn